Literature DB >> 22356569

Lactate clearance in cardiogenic shock following ST elevation myocardial infarction: a pilot study.

Paola Attaná1, Chiara Lazzeri, Marco Chiostri, Claudio Picariello, Gian Franco Gensini, Serafina Valente.   

Abstract

BACKGROUND: Recent studies documented that serial lactate measurements over time may be clinically more reliable than lactate absolute value for risk stratification. The aim of the present investigation was to assess the role of lactate clearance in predicting early death in cardiogenic shock (CS) following ST-elevation myocardial infarction (STEMI) submitted to primary percutaneous coronary intervention (PCI).
METHODS: 51 consecutive patients with CS following STEMI were prospectively enrolled. Lactate was measured in Intensive Cardiac Care Unit (ICCU) on admission and on the twelfth hour. Logistic regression analysis was performed to identify the independent predictors for in-ICCU mortality. Receiver operating characteristic (ROC) curve was constructed in order to identify cut-off for admission lactate and for 12-h lactate clearance in relation to in-ICCU mortality. Follow-up survival rate were investigated by Kaplan-Meier curves.
RESULTS: At 12 h from admission, lactate clearance was higher in survivors (P=0.013). A higher in-ICCU mortality was observed in patients with 12 hours lactate clearance<10% (P=0.002). At follow up, patients with 12-h lactate clearance<10% showed a significantly lower survival rate.
CONCLUSIONS: In patients with CS following STEMI, 12-h lactate clearance<10% identifies a subset of patients at higher risk for death at short and long-term.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22356569     DOI: 10.3109/17482941.2011.655293

Source DB:  PubMed          Journal:  Acute Card Care        ISSN: 1748-2941


  19 in total

Review 1.  Cellular responses to mild heat stress.

Authors:  H G Park; S I Han; S Y Oh; H S Kang
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

Review 2.  [Mechanical support in cardiogenic shock].

Authors:  T Graf; H Thiele
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

Review 3.  [Cardiac support and replacement systems].

Authors:  T Graf; H Thiele
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-05-02       Impact factor: 0.840

Review 4.  [Cardiogenic shock : Current evidence].

Authors:  H Thiele
Journal:  Herz       Date:  2017-12       Impact factor: 1.443

Review 5.  Etiology and therapeutic approach to elevated lactate levels.

Authors:  Lars W Andersen; Julie Mackenhauer; Jonathan C Roberts; Katherine M Berg; Michael N Cocchi; Michael W Donnino
Journal:  Mayo Clin Proc       Date:  2013-10       Impact factor: 7.616

Review 6.  Laboratory Predictors of Prognosis in Cardiogenic Shock Complicating Acute Myocardial Infarction.

Authors:  Tamilla Muzafarova; Zuzana Motovska
Journal:  Biomedicines       Date:  2022-06-05

7.  Early postictal serum lactate concentrations are superior to serum creatine kinase concentrations in distinguishing generalized tonic-clonic seizures from syncopes.

Authors:  Oliver Matz; Jan Heckelmann; Sebastian Zechbauer; Jens Litmathe; Jörg C Brokmann; Klaus Willmes; Jörg B Schulz; Manuel Dafotakis
Journal:  Intern Emerg Med       Date:  2017-09-12       Impact factor: 3.397

Review 8.  Clinical significance of lactate in acute cardiac patients.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Gian Franco Gensini
Journal:  World J Cardiol       Date:  2015-08-26

9.  Lactate and lactate clearance in acute cardiac care patients.

Authors:  Paola Attanà; Chiara Lazzeri; Claudio Picariello; Carlotta Sorini Dini; Gian Franco Gensini; Serafina Valente
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-06

10.  Clinical outcomes of patients with acute myocardial infarction complicated by severe refractory cardiogenic shock assisted with percutaneous cardiopulmonary support.

Authors:  Taek Kyu Park; Jeong Hoon Yang; Seung-Hyuk Choi; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Kiick Sung; Young Tak Lee; Hyeon-Cheol Gwon; Sang Hoon Lee
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.